Search clinical trials for: Placebo (linagliptin)
Total 53959 results
-
Lund UniversityCompletedHealthy | Type 2 DiabetesSweden
-
University of Oslo School of PharmacyOslo University HospitalCompleted
-
Kowa Research Institute, Inc.Completed
-
Hannover Medical SchoolUnknown
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Russian Federation, Ukraine
-
Korea University Anam HospitalCompletedDiabetes MellitusKorea, Republic of
-
Albert Einstein College of MedicineCompleted
-
Merck Sharp & Dohme LLCCompleted
-
CymaBay Therapeutics, Inc.Completed
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Merck Sharp & Dohme LLCCompletedHypoglycemia | Type 1 DiabetesNetherlands
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusCanada, United States, Italy, Poland, Puerto Rico
-
Ono Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
Merck Sharp & Dohme LLCCompleted
-
Rabin Medical CenterTerminatedGlucose Metabolism Disorders | Respiratory Tract Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | COVID 19 | Coronavirus | Metabolic Disease | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2 | Hormones | Hypoglycemic Agents | Incretins | Dipeptidyl-Peptidase IV Inhibitors and other conditionsIsrael
-
Washington University School of MedicineMerck Sharp & Dohme LLCCompletedPosttransplant Diabetes MellitusUnited States
-
University at BuffaloMerck Sharp & Dohme LLCCompletedType 2 DiabetesUnited States
-
Merck Sharp & Dohme LLCDuke Clinical Research Institute, Oxford Diabetes Trials UnitCompletedType 2 Diabetes Mellitus
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Greece, Taiwan
-
Lund UniversityMerck Sharp & Dohme LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Canada, Hungary, India, Spain, Puerto Rico
-
University Hospital, Gentofte, CopenhagenCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Ministry of Public Health, ArgentinaAix Marseille Université; Instituto de Biología y Medicina Experimental, IBYME...Unknown
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Germany, United Kingdom, Austria
-
University of PennsylvaniaRecruitingHeart Failure | Type2 Diabetes | Genetics DiseaseUnited States
-
Li BoCompletedType 2 Diabetes Mellitus | AtherosclerosisChina
-
GlaxoSmithKlineCompleted
-
University of Alabama at BirminghamTerminatedType 2 Diabetes MellitusUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Merck Sharp & Dohme LLCCompleted
-
TakedaTerminatedGlycemic ControlUnited States, Bulgaria, Malaysia, Korea, Republic of, Australia, Czech Republic, Hungary, Thailand, Italy, Slovakia, Croatia
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University Hospital, Gentofte, CopenhagenMerck Sharp & Dohme LLCCompletedType 2 DiabetesDenmark
-
Instituto Nacional de Ciencias Medicas y Nutricion...Merck Sharp & Dohme LLCCompletedReactive HypoglycemiaMexico
-
Boehringer IngelheimCompleted
-
Merck Sharp & Dohme LLCTerminated
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Withdrawn
-
Merck Sharp & Dohme LLCCompleted
-
Michael A. NauckCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Mexico
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioCompletedInsulin Resistance | Prediabetic StateMexico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Garvan Institute of Medical ResearchCompleted
-
Johns Hopkins UniversityMerck Sharp & Dohme LLCTerminatedGlucose HomeostasisUnited States
-
Merck Sharp & Dohme LLCCompleted